PATENT CLAIM ANALYSIS

Application Number: 15993232
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "699000"]

Abstract:
The subject invention pertains to myricanol derivatives, therapeutic compositions, and methods for treatment of neurodegenerative diseases, in particular, neurodegenerative dieses associated with abnormal accumulation of protein tau.

Claim (Index 10):
The method of  claim 9 , wherein the neurodegenerative disease is selected from Alzheimer's disease, Parkinson's disease, frontotemporal dementia, frontotemporal dementia with Parkinsonism, frontotemporal lobe dementia, pallidopontonigral degeneration, progressive supranuclear palsy, multiple system tauopathy, multiple system tauopathy with presenile dementia, Wilhelmsen-Lynch disease, Pick's disease, and Pick's disease-like dementia.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 93.0
- Lexical Diversity: 1.18519
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14390960', '15414242', '14486679', '13810362', '13884061']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7315288983930902
- 35 USC 102 Novelty (BERT): 0.5330381974660232
- Combined Prediction Score: 0.7116798283003836
- Mean Citation Score: 268.594884
- Max Citation Score: 342.55923
- Similarity Product: 293.45491439258694

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test